or Try an Advanced Search...

    Galmed Pharmaceuticals Ltd. Stocks List

    Symbol Grade Name % Change
    ETNB F 89bio, Inc. 2.25
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Alcohol Biopharmaceutical Hepatitis Innovative Therapies Medicine Metabolic Disease Non Alcoholic Fatty Liver Disease Steatohepatitis

    Related ETFs - A few ETFs which own one or more of the above listed Galmed Pharmaceuticals Ltd. stocks.

    Symbol Grade Name Weight
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.73
    SBIO D ALPS Medical Breakthroughs ETF 0.59
    XBI D SPDR S&P Biotech ETF 0.53
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.4
    BTEC D Principal Healthcare Innovators Index ETF 0.22
    View all Galmed Pharmaceuticals Ltd. ETFs...
    Compare ETFs
    Compare BBC to LABU Compare BBC to SBIO Compare SBIO to LABU

        Galmed Pharmaceuticals Ltd. Stocks Recent News

        Date Stock Title
        Apr 17 ETNB 89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
        Related Industries: Biotechnology
        Related Stock Lists: Alcohol Biopharmaceutical Hepatitis Innovative Therapies Medicine Metabolic Disease Non Alcoholic Fatty Liver Disease Steatohepatitis
        Galmed Pharmaceuticals Ltd.

        Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for the treatment of liver diseases and cholesterol gallstones. The company's lead product candidate, Aramchol, is a once-daily, oral therapy for the treatment of non-alcoholic steatohepatitis (NASH).

        Browse All Tags